About This Site

This website provides educational information about GLP-1 weight loss medications, including semaglutide and tirzepatide. Our goal is to help people understand their treatment options, compare medications, and make informed decisions about their health in consultation with licensed healthcare providers.

We believe accurate, accessible health information should not be gated behind paywalls or buried in clinical jargon. Every page on this site is written to be understandable, evidence-based, and transparent about what these medications can and cannot do.

This site has an affiliate relationship with VivioMD. When you click certain links on this site and make a purchase or sign up for a service, we may receive compensation from VivioMD.

This financial relationship does not influence our editorial content. We provide factual information about GLP-1 medications based on published clinical research, FDA documentation, and publicly available medical literature. We do not make unverified health claims, guarantee outcomes, or suppress relevant safety information for commercial reasons.

Our recommendations are based on product quality, pricing competitiveness, formulation variety, provider licensing, and accessibility. VivioMD is featured because it meets these criteria — not solely because of our affiliate relationship.

All affiliate links on this site are marked with rel="nofollow sponsored" in accordance with search engine guidelines.

Our content development process follows these principles:

• Source-based research: Content is developed from peer-reviewed medical literature, FDA approval documents, clinical trial publications (STEP, SURMOUNT), and established medical references.
• Citations provided: Medical claims are accompanied by source references. Key studies are cited by author, publication, and year.
• Accuracy review: Content is reviewed for factual accuracy and updated when new clinical data or regulatory changes occur.
• Limitations acknowledged: We clearly state when compounded medications are not FDA-approved products, when results may vary, and when readers should consult their own healthcare provider.

This website is for informational purposes only and does not constitute medical advice, diagnosis, or treatment.

The information on this site should not be used as a substitute for professional medical advice. Always consult a licensed healthcare provider before starting, stopping, or changing any medication or treatment plan.

GLP-1 medications carry risks and side effects that should be evaluated by a qualified clinician in the context of your individual health history. The clinical trial results referenced on this site represent population averages — individual results may vary significantly.

Compounded medications are not FDA-approved products. They are prepared by US-licensed compounding pharmacies under regulatory oversight but have not undergone the FDA approval process applicable to brand-name drugs.

No content on this site should be interpreted as a guarantee of weight loss outcomes, medication availability, or treatment suitability.

For questions about the content on this site or our editorial process, you can reach us through the website contact methods.

For medical questions or concerns about your treatment, please contact your VivioMD provider directly through the Tellescope patient portal or reach out to OpenLoop Healthcare Partners.